The outcome of I-131 therapy with fixed doses for Graves disease and toxic nodular/multinodular goiter in endemic region

Basit Öğe Kaydı
dc.contributor.authorSerdengecti, Mustafa
dc.contributor.authorSari, Oktay
dc.date.accessioned2020-03-26T18:17:04Z
dc.date.available2020-03-26T18:17:04Z
dc.date.issued2011
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.issn0161-5505en_US
dc.identifier.issn1535-5667en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/26974
dc.identifier.volume52en_US
dc.identifier.wosWOS:000443798901384en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSOC NUCLEAR MEDICINE INCen_US
dc.relation.ispartofJOURNAL OF NUCLEAR MEDICINEen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleThe outcome of I-131 therapy with fixed doses for Graves disease and toxic nodular/multinodular goiter in endemic regionen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu